Ustekinumab as Induction and Maintenance Therapy in Patients with Inflammatory Bowel Disease and Type II Autoimmune Pancreatitis: Report of Two Cases.

IF 8.3 2区医学 Q1 GASTROENTEROLOGY & HEPATOLOGY

Journal of Crohns & Colitis Pub Date : 2023-10-20 DOI:10.1093/ecco-jcc/jjad072

Gaetano Lauri, Ferdinando D'Amico, Mariangela Allocca, Diego Palumbo, Emanuel Della-Torre, Francesco De Cobelli, Claudio Doglioni, Paolo Giorgio Arcidiacon, Gabriele Capurso, Silvio Danese

引用次数: 0

查看原文本刊更多论文

Ustekinumab作为炎症性肠病和II型自身免疫性胰腺炎患者的诱导和维持治疗：两例报告。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Crohns & Colitis 医学-胃肠肝病学

CiteScore

15.50

自引率

7.50%

发文量

1048

审稿时长

1 months

期刊介绍： Journal of Crohns and Colitis is concerned with the dissemination of knowledge on clinical, basic science and innovative methods related to inflammatory bowel diseases. The journal publishes original articles, review papers, editorials, leading articles, viewpoints, case reports, innovative methods and letters to the editor.